Close Menu

NEW YORK (360Dx) – MedMira said today that it has received CE marking for its Multiplo TP/HIV multiplex rapid test, allowing the firm to market and distribute the test throughout the European Union, and in global markets that accept products with CE marking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.